102 related articles for article (PubMed ID: 34627429)
21. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
22. FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.
Zhong-Xing Z; Yuan-Yuan M; Hai Zhen M; Jian-Gang Z; Li-Feng Z
PLoS One; 2013; 8(8):e73700. PubMed ID: 24014103
[TBL] [Abstract][Full Text] [Related]
23. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
24. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
[TBL] [Abstract][Full Text] [Related]
26. Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin's Lymphoma.
Liu ZH; Zhang L; Jing FJ; Xiao SX; Gao Y; Bian HY; Zhao X
J Inflamm Res; 2021; 14():5687-5697. PubMed ID: 34754215
[TBL] [Abstract][Full Text] [Related]
27. Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients.
Crossen PE; Morrison MJ; Colls BM
Cancer Genet Cytogenet; 1995 Jan; 79(1):70-3. PubMed ID: 7850755
[TBL] [Abstract][Full Text] [Related]
28. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
29. The role of FAS gene variants in inflammatory bowel disease.
Demir A; Kahraman R; Candan G; Ergen A
Turk J Gastroenterol; 2020 May; 31(5):356-361. PubMed ID: 32519954
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese.
Nakagawa A; Nakamura S; Koshikawa T; Nakayama A; Nagasaka T; Motoori T; Kojima M; Hosomura Y; Ueda R; Mori S
Acta Pathol Jpn; 1993; 43(1-2):44-54. PubMed ID: 8465656
[TBL] [Abstract][Full Text] [Related]
31. [Effect of PD-1, FOXP3 and CSF-1R Protein Expression on the Prognosis of Patients with Hodgkin's Lymphoma].
Li XJ; He L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1372-1377. PubMed ID: 30295253
[TBL] [Abstract][Full Text] [Related]
32. Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients.
Bäumler C; Duan F; Onel K; Rapaport B; Jhanwar S; Offit K; Elkon KB
Leuk Res; 2003 Sep; 27(9):841-51. PubMed ID: 12804643
[TBL] [Abstract][Full Text] [Related]
33. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
[TBL] [Abstract][Full Text] [Related]
34. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma.
Weiner AS; Beresina OV; Voronina EN; Voropaeva EN; Boyarskih UA; Pospelova TI; Filipenko ML
Leuk Res; 2011 Apr; 35(4):508-15. PubMed ID: 21055808
[TBL] [Abstract][Full Text] [Related]
36. Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.
Liu D; Xu W; Ding X; Yang Y; Lu Y; Fei K; Su B
Cancer Biol Ther; 2017 Dec; 18(12):948-957. PubMed ID: 28278082
[TBL] [Abstract][Full Text] [Related]
37. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.
Grønbaek K; Straten PT; Ralfkiaer E; Ahrenkiel V; Andersen MK; Hansen NE; Zeuthen J; Hou-Jensen K; Guldberg P
Blood; 1998 Nov; 92(9):3018-24. PubMed ID: 9787134
[TBL] [Abstract][Full Text] [Related]
38. Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma.
Maggio EM; Van Den Berg A; de Jong D; Diepstra A; Poppema S
Am J Pathol; 2003 Jan; 162(1):29-35. PubMed ID: 12507887
[TBL] [Abstract][Full Text] [Related]
39. Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomas.
Xerri L; Carbuccia N; Parc P; Birg F
Am J Clin Pathol; 1995 Oct; 104(4):424-30. PubMed ID: 7572793
[TBL] [Abstract][Full Text] [Related]
40. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
